IL142631A0 - 13-membered azalides and their use as antibiotic agents - Google Patents

13-membered azalides and their use as antibiotic agents

Info

Publication number
IL142631A0
IL142631A0 IL14263199A IL14263199A IL142631A0 IL 142631 A0 IL142631 A0 IL 142631A0 IL 14263199 A IL14263199 A IL 14263199A IL 14263199 A IL14263199 A IL 14263199A IL 142631 A0 IL142631 A0 IL 142631A0
Authority
IL
Israel
Prior art keywords
antibiotic agents
membered azalides
azalides
membered
antibiotic
Prior art date
Application number
IL14263199A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22327457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL142631(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL142631A0 publication Critical patent/IL142631A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL14263199A 1998-11-20 1999-11-09 13-membered azalides and their use as antibiotic agents IL142631A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10939998P 1998-11-20 1998-11-20
PCT/IB1999/001803 WO2000031097A1 (fr) 1998-11-20 1999-11-09 Azalides a 13 elements et leur utilisation en tant qu'antibiotiques

Publications (1)

Publication Number Publication Date
IL142631A0 true IL142631A0 (en) 2002-03-10

Family

ID=22327457

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14263199A IL142631A0 (en) 1998-11-20 1999-11-09 13-membered azalides and their use as antibiotic agents
IL142631A IL142631A (en) 1998-11-20 2001-04-16 13-membered azalides, their preparation and pharmaceutical compositions containing them
IL189430A IL189430A (en) 1998-11-20 2008-02-11 13-membered azalides and their use as antibiotic agents

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL142631A IL142631A (en) 1998-11-20 2001-04-16 13-membered azalides, their preparation and pharmaceutical compositions containing them
IL189430A IL189430A (en) 1998-11-20 2008-02-11 13-membered azalides and their use as antibiotic agents

Country Status (46)

Country Link
US (1) US6329345B1 (fr)
EP (1) EP1131331B1 (fr)
JP (1) JP3842973B2 (fr)
KR (1) KR100477774B1 (fr)
CN (2) CN1326460A (fr)
AP (1) AP2001002142A0 (fr)
AR (3) AR019496A1 (fr)
AT (1) ATE260927T1 (fr)
AU (1) AU766106B2 (fr)
BG (1) BG65107B1 (fr)
BR (2) BRPI9915480B1 (fr)
CA (1) CA2351429C (fr)
CO (1) CO5380019A1 (fr)
CZ (1) CZ303099B6 (fr)
DE (1) DE69915336T2 (fr)
DK (1) DK1131331T3 (fr)
DZ (1) DZ2944A1 (fr)
EA (2) EA005156B1 (fr)
EG (1) EG23823A (fr)
ES (1) ES2216581T3 (fr)
GT (1) GT199900198A (fr)
HK (1) HK1041269A1 (fr)
HR (1) HRP20010374B1 (fr)
HU (1) HU229008B1 (fr)
ID (1) ID28548A (fr)
IL (3) IL142631A0 (fr)
IS (1) IS2350B (fr)
MA (1) MA26707A1 (fr)
ME (1) ME00467B (fr)
MY (1) MY122353A (fr)
NO (3) NO319796B1 (fr)
NZ (1) NZ511199A (fr)
OA (1) OA11713A (fr)
PA (1) PA8485601A1 (fr)
PE (1) PE20001378A1 (fr)
PL (1) PL198580B1 (fr)
PT (1) PT1131331E (fr)
RS (1) RS50302B (fr)
SI (1) SI1131331T1 (fr)
SK (1) SK284607B6 (fr)
TN (1) TNSN99214A1 (fr)
TW (2) TWI243824B (fr)
UA (1) UA70972C2 (fr)
UY (1) UY25805A1 (fr)
WO (1) WO2000031097A1 (fr)
ZA (1) ZA200104019B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
HUP0201516A3 (en) * 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
BR0110382A (pt) * 2000-04-27 2003-06-24 Pfizer Prod Inc Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
RU2263117C2 (ru) * 2001-04-27 2005-10-27 Пфайзер Продактс Инк. Способ получения 4"-замещенных производных 9-деоксо-9а-аза-9а-гомоэритромицина а
WO2003014136A1 (fr) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. Composes de 11a-azalide et methode de production de ces composes
EP1638549A4 (fr) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc Nouveaux agents antibacteriens
WO2004108744A2 (fr) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides et azaketolides possedant une activite antimicrobienne
MXPA06005639A (es) * 2003-11-21 2006-08-17 Pfizer Prod Inc Adyuvante antimicrobiano.
US8097708B2 (en) * 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
JPWO2009019868A1 (ja) * 2007-08-06 2010-10-28 大正製薬株式会社 １０ａ、１２位架橋型１０ａ−アザライド化合物
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
WO2012038372A1 (fr) * 2010-09-20 2012-03-29 Novartis Ag Nouveau procédé de préparation de 9-déoxo-9a-aza-9a-homoérythromycine a modifiée dans le c-4'' du cycle cladinose par un groupe époxyde
CN102295672B (zh) * 2011-07-13 2014-06-04 武汉回盛生物科技有限公司 一种泰拉菌素的合成方法
EP2736915A1 (fr) 2011-07-27 2014-06-04 Farma GRS, d.o.o. Nouvelles formes cristallines de tulathromycine
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
EP3027634B1 (fr) * 2013-07-31 2018-03-21 Farma GRS, d.o.o. Procédé de préparation de tulathromycine
CN109748942A (zh) * 2014-05-16 2019-05-14 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
DK3883647T3 (da) * 2018-11-19 2026-03-23 Zikani Therapeutics Inc C10-alkylensubstituerede 13-ledede makrolider og anvendelser deraf
MX2021005421A (es) * 2018-11-19 2021-09-21 Zikani Therapeutics Inc Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos.
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
SI8611592A8 (en) * 1986-09-12 1995-04-30 Pliva Pharm & Chem Works Process for preparing complexes of N-methyl-11-aza-10-deoxo-10-dihydroeritromicine A and 11-aza-10-deoxo-10-dihydroeritromicine A with metals
US5106961A (en) 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
GB2327084A (en) * 1997-07-08 1999-01-13 Merck & Co Inc 9a-Aza-3-ketolide antibiotics
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
SK284607B6 (sk) 2005-07-01
BG105600A (en) 2001-12-29
AP2001002142A0 (en) 2001-05-09
MY122353A (en) 2006-04-29
KR100477774B1 (ko) 2005-03-21
PA8485601A1 (es) 2000-09-29
EP1131331B1 (fr) 2004-03-03
NO319796B1 (no) 2005-09-19
SK6632001A3 (en) 2002-07-02
YU33401A (sh) 2004-05-12
CN101367853A (zh) 2009-02-18
NO20012464L (no) 2001-07-17
EA009729B1 (ru) 2008-02-28
HUP0104313A2 (hu) 2002-02-28
OA11713A (en) 2005-01-25
DE69915336T2 (de) 2005-01-13
HUP0104313A3 (en) 2003-12-29
NO329629B1 (no) 2010-11-22
UA70972C2 (uk) 2004-11-15
ZA200104019B (en) 2002-06-17
CA2351429C (fr) 2005-07-12
EA005156B1 (ru) 2004-12-30
CA2351429A1 (fr) 2000-06-02
AU766106B2 (en) 2003-10-09
SI1131331T1 (en) 2004-08-31
KR20010086043A (ko) 2001-09-07
IS5918A (is) 2001-04-17
JP3842973B2 (ja) 2006-11-08
NO20050893L (no) 2001-07-17
ATE260927T1 (de) 2004-03-15
TW200404077A (en) 2004-03-16
BG65107B1 (bg) 2007-02-28
DZ2944A1 (fr) 2004-03-15
IS2350B (is) 2008-04-15
HU229008B1 (en) 2013-07-29
DK1131331T3 (da) 2004-06-14
NO20012464D0 (no) 2001-05-18
WO2000031097A1 (fr) 2000-06-02
AR059523A2 (es) 2008-04-09
BR9915480A (pt) 2001-07-31
HRP20010374A2 (en) 2002-06-30
ID28548A (id) 2001-05-31
US6329345B1 (en) 2001-12-11
HK1041269A1 (zh) 2002-07-05
PL198580B1 (pl) 2008-06-30
PL347784A1 (en) 2002-04-22
UY25805A1 (es) 2001-08-27
DE69915336D1 (de) 2004-04-08
BRPI9915480B1 (pt) 2015-12-29
AU1068600A (en) 2000-06-13
TNSN99214A1 (fr) 2005-11-10
MA26707A1 (fr) 2004-12-20
EP1131331A1 (fr) 2001-09-12
GT199900198A (es) 2001-05-11
RS50302B (sr) 2009-09-08
PT1131331E (pt) 2004-06-30
TWI243825B (en) 2005-11-21
EA200100416A1 (ru) 2001-10-22
HRP20010374B1 (en) 2006-09-30
NO20050904L (no) 2001-07-17
CZ303099B6 (cs) 2012-04-04
ME00467B (me) 2011-10-10
TWI243824B (en) 2005-11-21
NZ511199A (en) 2003-08-29
PE20001378A1 (es) 2000-12-14
JP2002530422A (ja) 2002-09-17
NO330249B1 (no) 2011-03-14
IL142631A (en) 2010-05-31
CZ20011754A3 (cs) 2002-03-13
EG23823A (en) 2007-09-19
CO5380019A1 (es) 2004-03-31
AR019496A1 (es) 2002-02-20
ES2216581T3 (es) 2004-10-16
BRPI9915480B8 (pt) 2022-05-10
EA200400701A1 (ru) 2004-12-30
AR059524A2 (es) 2008-04-09
IL189430A (en) 2010-05-31
CN1326460A (zh) 2001-12-12
IL189430A0 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
IL189430A0 (en) 13-membered azalides and their use as antibiotic agents
AU1315797A (en) Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
AU2001272935A1 (en) Cobalamin compounds useful as antibiotic agents and as imaging agents
AU3352097A (en) Substituted piperazinyl-phenyl-oxazolidinone derivatives and their use as anti-bacterial agents
GB9813271D0 (en) Composition and use
AU7124398A (en) Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
HUP0103845A3 (en) Disinfecting composition and its use
HUP0105364A3 (en) Spontaneously dispersible n-benzoyl staurosporine compositions and their use
HUP0101817A3 (en) 15-membered lactams ketolides and pharmaceutical compositions comprising them with antibacterial activity
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
HUP0102808A3 (en) Ectoparasiticide agents
GB9803232D0 (en) Compound composition and use
AU5789001A (en) Macrolide antiinfective agents
GB9724859D0 (en) Compounds and their use as antibacterial agents
AU4129800A (en) Bis-benzazoles and their use as antineoplastic agents
AU3617799A (en) Improvements in or relating to contrast agents
SG80037A1 (en) Potassium channel drugs and their uses
AU1978397A (en) Urea nucleosides as therapeutic and diagnostic agents
AU3432900A (en) Colouring agent and the use thereof
GB9914346D0 (en) Antibiotic agents
GB9911606D0 (en) Composition and use
GB9805172D0 (en) Composition and use
GB9809219D0 (en) Antibiotic agents
PL346903A1 (en) Sulfonyltriazol derivatives and their use for combating micro-organisms